Before revision: The FDA approved the drug under the brand name RhoGAM, with a fixed dose of 300 µG , to be given within three days (72 hours) postpartum.
After revision: The FDA approved the drug under the brand name RhoGAM, with a fixed dose of 300 µg , to be given within three days (72 hours) postpartum.